Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

RE:RE:RE:RE:RE:RE:RE:Photodynamic therapy combined with immunotherapy: Nov 15/23

Good post Longholder99. In terms of patient welfare, it's gratifying to...

November 17, 2023

V.TLT

RE:RE:RE:RE:RE:Photodynamic therapy combined with immunotherapy: Nov 15/23

In case anyone missed it, Theralase applied for a new patent last month: ...

November 16, 2023

V.TLT

RE:the PP....

We should also be getting an update soon. On October 23 Dr. Mandel wrote:&...

November 15, 2023

V.TLT

New Paper on Ruthenium-based PDT and Oral Cancer

Hyaluronic acid-poly(lactic-co-glycolic acid) nanoparticles with a ruthenium...

November 15, 2023

V.TLT

Anybody near Athens Ohio tomorrow afternoon?

Professor Sherri McFarland will be presenting the Chemistry &...

November 14, 2023

V.TLT

Dr. McFarland to speak in Hong Kong Nov 27

4th International Conference on Photopharmacology November 27-29, 2023 Li Ka...

November 10, 2023

V.TLT

RE:RE:RE:Pre-BTD expectations in August vs October

Yes. I don't think there was anything new in this interview.  I don...

November 8, 2023

V.TLT

RE:Pre-BTD expectations in August vs October

The Market Herald article says: "Over the next six months the company...

November 8, 2023

V.TLT

RE:RE:RE:RE:RE:RE:pre-BTD and BTD

From the start the protocol of the trial was 2 treatments - one at 3 months...

November 7, 2023

V.TLT

RE:RE:RE:RE:Excellent News

It's pre-BTD submission by year end. I misread the email announcement...

November 6, 2023

V.TLT

RE:RE:Excellent News

The great news is that Theralase has confirmed they will submit the BTD...

November 6, 2023

V.TLT

Dana-Farber Cancer Institute a Clinical Study Site?

I wonder what this is about? The Dana-Farber Cancer Institute in Boston...

November 2, 2023

V.TLT

Another research paper on Ruthenium based PDCs

BODIPY-ruthenium(II) polypyridyl complexes: Synthesis, computational...

October 29, 2023

V.TLT

RE:Immunity Bio application accepted by FDA

How do the results of our current trial compare?  ImmunityBio's...

October 26, 2023

V.TLT

RE:RE:RE:RE:RE:RE:FDA

Thanks Oden6570! My bad. Belated remedial action employed! Oden6570 wrote...

October 25, 2023

V.TLT

RE:RE:RE:RE:RE:FDA

Read the news releases. This is from 9 days ago: "Mr. Roger DuMoulin...

October 25, 2023

V.TLT

RE:RE:RE:FDA

They are 38 patients left to treat not 48. Dumbeldorfwhite wrote: Heard that...

October 25, 2023

V.TLT

RE:RE:RE:FDA

They do know it's safe because the affected patients were underdosed...

October 25, 2023

V.TLT

RE:RE:RE:RE:RE:well just maybe

I sincerely doubt Merck considers us a threat in the BCG-unresponsive NMIBC...

October 25, 2023

V.TLT

RE:FDA

Because even with an inadequate dose the results were better than all...

October 25, 2023

Featured Company